Autoantigens are self-derived molecules that become recognized by the adaptive immune system after tolerance is lost. They may be intracellular enzymes, nuclear ribonucleoproteins, membrane receptors, structural matrix proteins, microbial-response proteins, or tissue-restricted differentiation antigens. In autoimmune and immune-mediated diseases, the target profile is not simply a diagnostic label; it reflects the tissue compartment exposed to inflammation, the route of antigen presentation, the immunoglobulin class or subclass involved, and the effector mechanisms that translate autoantibody binding into tissue injury. For reagent development, assay design, and mechanistic research, each autoantigen should therefore be considered in relation to its native localization, conformational state, post-translational modification, biological function, and disease-associated epitope pattern.
Primary biliary cholangitis is a chronic autoimmune cholestatic liver disease targeting small intrahepatic bile ducts. Its serological signature is antimitochondrial antibody reactivity, especially against the E2 subunit of the pyruvate dehydrogenase complex. PBC also includes disease-specific antinuclear antibodies directed against nuclear pore and nuclear body antigens, such as gp210 and sp100. These targets help explain why a tissue-specific disease can involve antigens that are widely expressed: biliary epithelial cells may uniquely modify, present, or fail to clear mitochondrial and nuclear antigens during apoptosis and cholangiocyte stress.
Several recurring mechanisms explain how normally tolerated proteins become immunogenic. Cell stress, apoptosis, necrosis, degranulation, extracellular trap formation, defective clearance of immune complexes, microbial mimicry, and oxidative or enzymatic modification can all increase antigen availability. Once antigen is released or redistributed, antigen-presenting cells process peptides and activate autoreactive T cells. B cells receiving T-cell help undergo clonal expansion, affinity maturation, and class switching, producing antibodies that may serve as biomarkers, pathogenic mediators, or both. The clinical value of an autoantigen depends on antigen quality: recombinant proteins should preserve relevant epitopes, native proteins may retain conformational and post-translational features, and peptide antigens are useful when the dominant epitope is linear and well defined.
Fig. 1 Mechanisms of Immunogenicity in Primary Biliary Cholangitis (PBC)
The classical and commonly used targets for this material document include:
These targets should be selected according to the intended research question, assay platform, desired sensitivity and specificity, sample matrix, and whether the study requires native conformational epitopes, recombinant full-length protein, antigenic domains, or synthetic peptide epitopes.
| Target | Location | Function | Immunological Role |
| PDC-E2 | Mitochondrial inner membrane enzyme complex | Pyruvate dehydrogenase activity in energy metabolism | Dominant AMA target in PBC |
| BCOADC-E2 | Mitochondrial branched-chain oxoacid dehydrogenase complex | Branched-chain amino acid catabolism | AMA target contributing to M2 antigen profile |
| OGDC-E2 | Mitochondrial 2-oxoglutarate dehydrogenase complex | Tricarboxylic acid cycle metabolism | AMA-associated mitochondrial antigen |
| gp210 | Nuclear pore complex membrane protein | Nuclear-cytoplasmic transport structure | PBC-specific ANA associated with disease severity in some studies |
| sp100 | Nuclear dots/PML nuclear bodies | Transcriptional and antiviral nuclear body function | PBC-specific ANA target |
| PML protein | Nuclear bodies | Tumor suppressor and antiviral response organization | Nuclear dot antigen related to PBC ANA patterns |
| Centromere proteins | Centromeres | Chromosome segregation | Associated with PBC-systemic sclerosis overlap and portal hypertension risk contexts |
| KLHL12 and hexokinase 1 | Cytoplasmic/metabolic and ubiquitin-related compartments | Protein trafficking/metabolism | Emerging PBC-associated antibodies |
PDC-E2 contains lipoic acid-dependent epitopes that are central to PBC serology. Its apoptotic preservation in cholangiocytes may promote immune recognition.
Localization and function: PDC-E2 is primarily associated with mitochondrial inner membrane enzyme complex. Its biological role centers on pyruvate dehydrogenase activity in energy metabolism. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Dominant AMA target in PBC. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
BCOADC-E2 shares structural features with PDC-E2 and broadens antimitochondrial reactivity.
Localization and function: BCOADC-E2 is primarily associated with mitochondrial branched-chain oxoacid dehydrogenase complex. Its biological role centers on branched-chain amino acid catabolism. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: AMA target contributing to M2 antigen profile. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
OGDC-E2 is another 2-oxoacid dehydrogenase family member involved in the PBC mitochondrial antigen cluster.
Localization and function: OGDC-E2 is primarily associated with mitochondrial 2-oxoglutarate dehydrogenase complex. Its biological role centers on tricarboxylic acid cycle metabolism. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: AMA-associated mitochondrial antigen. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-gp210 produces nuclear rim staining and is useful when AMA is negative or for risk stratification research.
Localization and function: gp210 is primarily associated with nuclear pore complex membrane protein. Its biological role centers on nuclear-cytoplasmic transport structure. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: PBC-specific ANA associated with disease severity in some studies. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-sp100 produces multiple nuclear dot staining and is highly specific in appropriate clinical context.
Localization and function: sp100 is primarily associated with nuclear dots/pml nuclear bodies. Its biological role centers on transcriptional and antiviral nuclear body function. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: PBC-specific ANA target. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
PML contributes to nuclear body architecture and may be recognized in ANA-positive PBC.
Localization and function: PML protein is primarily associated with nuclear bodies. Its biological role centers on tumor suppressor and antiviral response organization. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Nuclear dot antigen related to PBC ANA patterns. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-centromere antibodies may appear in PBC, particularly with limited systemic sclerosis features.
Localization and function: Centromere proteins is primarily associated with centromeres. Its biological role centers on chromosome segregation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Associated with PBC-systemic sclerosis overlap and portal hypertension risk contexts. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
These newer antigens may improve detection in AMA-negative PBC and refine disease subgroups.
Localization and function: KLHL12 and hexokinase 1 is primarily associated with cytoplasmic/metabolic and ubiquitin-related compartments. Its biological role centers on protein trafficking/metabolism. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Emerging PBC-associated antibodies. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
References
